Skip to content

Clinical trials

Phase 1 Melanoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 1 Country / region: France Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20115
20136
20153
20164
20176
20182
20196
20206
20212
20224
20232
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Terminated15
Active, not recruiting7
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Eli Lilly and Company4
Novartis Pharmaceuticals4
GlaxoSmithKline3
Hoffmann-La Roche3
Pierre Fabre Medicament3
AbbVie2
Amgen2
Bayer2
Dragonfly Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma54
Carcinoma, Non-Small-Cell Lung24
Squamous Cell Carcinoma of Head and Neck13
Colorectal Neoplasms12
Neoplasms12
Carcinoma, Renal Cell9
Ovarian Neoplasms9
Triple Negative Breast Neoplasms9
Stomach Neoplasms7
Breast Neoplasms5

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.